Department of Education and Research, Taichung Veterans General Hospital, Taichung 407, Taiwan.
J Nutr Biochem. 2012 Mar;23(3):252-64. doi: 10.1016/j.jnutbio.2010.11.022. Epub 2011 Apr 15.
Bile duct obstruction and subsequent cholestasis are associated with hepatocellular injury, cholangiocyte proliferation, stellate cell activation, Kupffer cell activation, oxidative stress, inflammation and fibrosis. Docosahexaenoic acid (DHA) is an essential polyunsaturated fatty acid that has been shown to possess health beneficial effects, including hepatoprotection. However, the molecular mechanism of DHA-mediated hepatoprotection is not fully understood. In the present study, we report the protective effect of DHA on cholestatic liver injury. Cholestasis was produced by bile duct ligation (BDL) in male Sprague-Dawley rats for 3 weeks. Daily administration of DHA was started 2 weeks before injury and lasted for 5 weeks. In comparison with the control group, the BDL group showed hepatic damage as evidenced by histological changes and elevation in serum biochemicals, ductular reaction, fibrosis, inflammation and oxidative stress. These pathophysiological changes were attenuated by chronic DHA supplementation. DHA alleviated BDL-induced transforming growth factor beta-1 (TGF-β1), intereukin-1beta, connective tissue growth factor and collagen expression. The anti-fibrotic effect of DHA was accompanied by reductions in α-smooth muscle actin-positive matrix-producing cells and Smad 2/3 activity critical to the fibrogenic potential of TGF-β1. DHA also attenuated BDL-induced leukocyte accumulation and nuclear factor-κB (NF-κB) activation. Further studies demonstrated an inhibitory effect of DHA on redox-sensitive intracellular signaling molecule extracellular signal-regulated kinase (ERK). Taken together, the hepatoprotective, anti-inflammatory and anti-fibrotic effects of DHA seem to be multifactorial. The beneficial effects of chronic DHA supplementation are associated with anti-oxidative and anti-inflammatory potential as well as down-regulation of NF-κB and transforming growth factor beta/Smad signaling probably via interference with ERK activation.
胆管阻塞和随后的胆汁淤积与肝细胞损伤、胆管细胞增殖、星状细胞激活、枯否细胞激活、氧化应激、炎症和纤维化有关。二十二碳六烯酸 (DHA) 是一种必需的多不饱和脂肪酸,已被证明具有有益的健康作用,包括肝保护作用。然而,DHA 介导的肝保护的分子机制尚不完全清楚。在本研究中,我们报告了 DHA 对胆汁淤积性肝损伤的保护作用。通过胆管结扎 (BDL) 在雄性 Sprague-Dawley 大鼠中产生胆汁淤积,3 周。DHA 的每日给药在损伤前 2 周开始,并持续 5 周。与对照组相比,BDL 组表现出肝损伤,表现为组织学变化和血清生化指标升高、小管反应、纤维化、炎症和氧化应激。慢性 DHA 补充可减轻这些病理生理变化。DHA 减轻 BDL 诱导的转化生长因子β-1 (TGF-β1)、白细胞介素-1β、结缔组织生长因子和胶原蛋白表达。DHA 的抗纤维化作用伴随着α-平滑肌肌动蛋白阳性基质产生细胞和转化生长因子β1 纤维化潜能关键的 Smad 2/3 活性的减少。DHA 还减轻了 BDL 诱导的白细胞积聚和核因子-κB (NF-κB) 激活。进一步的研究表明,DHA 对氧化还原敏感的细胞内信号分子细胞外信号调节激酶 (ERK) 有抑制作用。总之,DHA 的肝保护、抗炎和抗纤维化作用似乎是多因素的。慢性 DHA 补充的有益作用与抗氧化和抗炎潜力有关,以及 NF-κB 和转化生长因子β/Smad 信号的下调可能与干扰 ERK 激活有关。